CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Net sales	$ 904	$ 951	$ 2,719	$ 2,888
Cost of products sold	463	456	1,322	1,376
Gross profit	441	495	1,397	1,512
Selling, general, and administrative expenses	355	390	1,055	1,204
Research and development expenses	37	40	110	123
Goodwill and intangible asset impairments	262	504	497	510
Restructuring and other costs	5	23	18	45
Operating loss	(218)	(462)	(283)	(370)
Other income and expenses:
Interest expense, net	23	18	66	53
Other income	(11)	(2)	(10)	(10)
Loss before income taxes	(230)	(478)	(339)	(413)
Provision for income taxes	198	17	114	69
Net loss	(428)	(495)	(453)	(482)
Less: Net loss attributable to noncontrolling interest	(1)	(1)	(1)	(2)
Net loss attributable to Dentsply Sirona	$ (427)	$ (494)	$ (452)	$ (480)
Loss per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ (2.14)	$ (2.46)	$ (2.27)	$ (2.35)
Diluted (in dollars per share)	$ (2.14)	$ (2.46)	$ (2.27)	$ (2.35)
Weighted average common shares outstanding:
Basic (in shares)	199.5	201.0	199.3	204.7
Diluted (in shares)	199.5	201.0	199.3	204.7